London Daily

Focus on the big picture.
Monday, Oct 06, 2025

US Grants Pfizer Covid Vaccine Full Approval

US Grants Pfizer Covid Vaccine Full Approval

Coronavirus: The move could trigger a new wave of vaccine mandates as the Delta variant batters the United States.

The US Food and Drug Administration on Monday fully approved the Pfizer-BioNTech Covid vaccine, a move expected to trigger a new wave of vaccine mandates as the Delta variant batters the country.

Around 52 percent of the country is fully vaccinated, but health authorities have hit a wall of vaccine hesitant people, impeding the national campaign.

"The FDA's approval of this vaccine is a milestone as we continue to battle the Covid-19 pandemic," acting FDA Commissioner Janet Woodcock said in a statement.

"While all three COVID vaccines have met FDA's strict standards for emergency use, this FDA approval should give added confidence that this vaccine is safe and effective. If you're not vaccinated yet, now is the time," tweeted President Joe Biden.

The vaccine, which will now be marketed under its brand name Comirnaty, is the first to receive full approval.

More than 200 million shots have already been administered under an emergency use authorization (EUA) that was granted on December 11, 2020.

The decision to approve it among people aged 16 and up was based on updated data from the drug's clinical trial, which found the vaccine more than 90 percent effective in preventing Covid.

"Overall, approximately 12,000 recipients have been followed for at least six months," the FDA said in its statement.

Most commonly reported side effects included pain, redness and swelling at the injection site, fatigue, headache, muscle or joint pain, chills and fever.

The FDA is continuing to investigate safety data regarding myocarditis (heart inflammation), particularly within seven days after the second dose. The data so far shows an increased risk among males under 40 compared to females and older males.

The highest risk has been detected in boys aged 12 through 17, with available data suggesting most individuals recover but some require intensive care.

The US military said shortly after the announcement that it would mandate the vaccine, and a slew of private businesses and universities are expected to follow.

Immediately after the announcement, New York City said it would require all its department of education employees to receive at least one dose of vaccine by September 27, without the option for regular testing instead.

The vaccine remains available under emergency use authorization to children aged 12 to 15, but because it has now been fully approved, physicians may prescribe it to children under 12 if they believe it will be beneficial.

Blow to anti-vaxxers


"One of the talking points of the anti-vaccine movement which has falsely claimed that this was an 'experimental vaccine' has been removed," Amesh Adalja of the Johns Hopkins University Center for Health Security told AFP.

"Hopefully now you'll see people who said that they were waiting for full approval line up to get vaccinated, hopefully more organizations, more businesses will require the vaccine as a condition of employment as a condition of participation."

A recent survey by the Kaiser Family Foundation found 30 percent of adults said full approval would make them more likely to get vaccinated.

It comes as the ultra-contagious Delta variant pummels the country, with new cases and hospitalizations approaching levels last seen during the winter wave.

The hardest hit regions include southern states Florida, Alabama, Mississippi and Louisiana.

The number of people rolling up their sleeves for a shot has risen in these states in recent weeks, but the national rate is still well below its peak from spring.

Some 628,000 people have died from coronavirus infection in the United States, making it officially the hardest hit country in the world -- though experts say it is possible that India may in fact hold the record.

Vaccines are less effective against the Delta variant than they were against previous strains, particularly against infection, making the goal of high population level vaccination critical.

The Biden administration announced last week plans to make a booster shot immediately available for immunocompromised individuals, and recommended all vaccinated people get a third shot eight months after their second.

Comments

Oh ya 4 year ago
"One of the talking points of the anti-vaccine movement which has falsely claimed that this was an 'experimental vaccine' has been removed," Amesh Adalja of the Johns Hopkins University Center for Health Security told AFP... Sorry to point this out there Amesh but even the inventors of this call it... Gene Therapy. A vaccine is something like the one for measles, this jab turns your body into a spike protein factory. (which in turn clogs up your vains thus the heart attacks and strokes) but carry on lying God will deal with you someday

Newsletter

Related Articles

0:00
0:00
Close
Three Scientists Awarded Nobel Prize in Medicine for Discovery of Immune Self-Tolerance Mechanism
OpenAI and AMD Forge Landmark AI-Chip Alliance with Equity Option
Munich Airport Reopens After Second Drone Shutdown
France Names New Government Amid Political Crisis
Trump Stands Firm in Shutdown Showdown and Declares War on Drug Cartels — Turning Crisis into Opportunity
Surge of U.S. Billionaires Transforms London’s Peninsula Apartments into Ultra-Luxury Stronghold
Pro Europe and Anti-War Babiš Poised to Return to Power After Czech Parliamentary Vote
Jeff Bezos Calls AI Surge a ‘Good’ Bubble, Urges Focus on Lasting Innovation
Japan’s Ruling Party Chooses Sanae Takaichi, Clearing Path to First Female Prime Minister
Sean ‘Diddy’ Combs Sentenced to Fifty Months in Prison Following Prostitution Conviction
Taylor Swift’s ‘Showgirl’ Launch Extends Billion-Dollar Empire
Trump Administration Launches “TrumpRx” Plan to Enable Direct Drug Sales at Deep Discounts
Trump Announces Intention to Impose 100 Percent Tariff on Foreign-Made Films
Altman Says GPT-5 Already Outpaces Him, Warns AI Could Automate 40% of Work
Singapore and Hong Kong Vie to Dominate Asia’s Rising Gold Trade
Trump Organization Teams with Saudi Developer on $1 Billion Trump Plaza in Jeddah
Manhattan Sees Surge in Office-to-Housing Conversions, Highest Since 2008
Switzerland and U.S. Issue Joint Assurance Against Currency Manipulation
Electronic Arts to Be Taken Private in Historic $55 Billion Buyout
Thomas Jacob Sanford Named as Suspect in Deadly Michigan Church Shooting and Arson
Russian Research Vessel 'Yantar' Tracked Mapping Europe’s Subsea Cables, Raising Security Alarms
New York Man Arrested After On-Air Confession to 2017 Parents’ Murders
U.S. Defense Chief Orders Sudden Summit of Hundreds of Generals and Admirals
Global Cruise Industry Posts Dramatic Comeback with 34.6 Million Passengers in 2024
Trump Claims FBI Planted 274 Agents at Capitol Riot, Citing Unverified Reports
India: Internet Suspended in Bareilly Amid Communal Clashes Between Muslims and Hindus
Supreme Court Extends Freeze on Nearly $5 Billion in U.S. Foreign Aid at Trump’s Request
Archaeologists Recover Statues and Temples from 2,000-Year-Old Sunken City off Alexandria
China Deploys 2,000 Workers to Spain to Build Major EV Battery Factory, Raising European Dependence
Speed Takes Over: How Drive-Through Coffee Chains Are Rewriting U.S. Coffee Culture
U.S. Demands Brussels Scrutinize Digital Rules to Prevent Bias Against American Tech
Ringo Starr Champions Enduring Beatles Legacy While Debuting Las Vegas Art Show
Private Equity’s Fundraising Surge Triggers Concern of European Market Shake-Out
Colombian President Petro Vows to Mobilize Volunteers for Gaza and Joins List of Fighters
FBI Removes Agents Who Kneeled at 2020 Protest, Citing Breach of Professional Conduct
Trump Alleges ‘Triple Sabotage’ at United Nations After Escalator and Teleprompter Failures
Shock in France: 5 Years in Prison for Former President Nicolas Sarkozy
Tokyo’s Jimbōchō Named World’s Coolest Neighbourhood for 2025
European Officials Fear Trump May Shift Blame for Ukraine War onto EU
BNP Paribas Abandons Ban on 'Controversial Weapons' Financing Amid Europe’s Defence Push
Typhoon Ragasa Leaves Trail of Destruction Across East Asia Before Making Landfall in China
The Personality Rights Challenge in India’s AI Era
Big Banks Rebuild in Hong Kong as Deal Volume Surges
Italy Considers Freezing Retirement Age at 67 to Avert Scheduled Hike
Italian City to Impose Tax on Visiting Dogs Starting in 2026
Arnault Denounces Proposed Wealth Tax as Threat to French Economy
Study Finds No Safe Level of Alcohol for Dementia Risk
Denmark Investigates Drone Incursion, Does Not Rule Out Russian Involvement
Lilly CEO Warns UK Is ‘Worst Country in Europe’ for Drug Prices, Pulls Back Investment
Nigel Farage Emerges as Central Force in British Politics with Reform UK Surge
×